.
MergerLinks Header Logo

New Deal


Announced

Completed

StatLab Medical Products completed the acquisition of Poly Scientific R&D.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

diagnostic chemicals

reagents

Specialty Chemicals

Acquisition

Majority

Friendly

United States

manufacturing company

Domestic

Private

Single Bidder

Completed

Synopsis

Edit

StatLab Medical Products, a developer and manufacturer of medical diagnostic supplies and equipment, completed the acquisition of Poly Scientific R&D, a US manufacturer and supplier of high-quality pathology stains, tissue controls, reagents and paraffin for anatomic pathology laboratories. Financial terms were not disclosed. “Our shared vision of delivering the highest quality products with a customer-centric approach makes the addition of Poly Scientific to the StatLab family of brands a natural fit. I look forward to partnering with Denise to build on the legacy the Caggiano family has established; our collaboration will strengthen the foundation already built through a commitment to manufacturing excellence, backed by the support and resources the StatLab organization can offer,” Sung-Dae Hong, StatLab CEO.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US